Results 281 to 290 of about 2,663,399 (366)
Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus
Abstract Aims To evaluate treatment‐emergent antidrug antibodies (TE ADA) in once‐weekly basal insulin efsitora‐treated participants with type 1 and type 2 diabetes mellitus (T1DM and T2DM) from 5 phase 3 clinical trials and their potential impact on pharmacokinetics, efficacy and safety.
Yun Wang +8 more
wiley +1 more source
Atopic Multimorbidity in Adults With a Focus on Sensitization Patterns and T Cell Activation. [PDF]
Bialas A +6 more
europepmc +1 more source
Abstract Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for type 2 diabetes mellitus and obesity, with once‐weekly dosing that supports adherence. However, injection‐site reactions (ISRs) and dermatologic events have been recognised, ranging from mild local events to rare systemic hypersensitivity reactions that may cause ...
Shifa Taj +6 more
wiley +1 more source
A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis. [PDF]
Dermiki-Gkana F +3 more
europepmc +1 more source
Evolving therapies for chronic spontaneous urticaria: Addressing unmet needs in adults and children. [PDF]
Bellanti JA, Settipane RA.
europepmc +1 more source
Spices, herbs and allergic reactions in children: myth or reality - a narrative review with scoping elements. [PDF]
Berghea EC +7 more
europepmc +1 more source

